In brief
Defence Secretary Pete Hegseth announced a new policy that will test every U.S. service member over 30 for low testosterone, offering voluntary replacement therapy. Men found below the threshold will receive options while men under 30 can opt in. The Pentagon has not revealed plans for women, sparking questions about gender inclusivity. The move builds on a prior push to ease prescribing testosterone, stirring debate over the army’s masculinity narrative. BBC analyst Gary O'Donoghue suggests the policy signals a broader commitment to a more male‑centric military culture.
U.S. military introduces testosterone screening for men 30 and older
Defence Secretary Pete Hegseth announced that all American service members aged thirty years and older will receive annual testosterone tests. Those whose levels fall below the threshold will be offered voluntary replacement therapy while their service status remains unchanged.
For men under thirty, testing will be optional, yet the Pentagon has yet to disclose whether women will have access to similar hormone‑replacement options.
The policy follows a broader trend that started in the previous administration to lower barriers for prescribing testosterone, sparking debate over both health and gender policy in the armed forces.
BBC’s Gary O'Donoghue interprets the move as part of Hegseth’s vision for a more “manly” military, stressing physical performance and traditional masculine values as key to national security.
